id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-S-0039-0304,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,Report,2012-09-23T04:00:00Z,2012,9,2012-09-23T04:00:00Z,,2016-09-30T14:24:45Z,,0,0,090000648055c329
FDA-1995-S-0039-0299,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,Report,2012-09-23T04:00:00Z,2012,9,2012-09-23T04:00:00Z,,2016-09-30T14:24:43Z,,0,0,090000648055c312
FDA-1995-S-0039-0307,FDA,FDA-1995-S-0039,"Attachment ""References"" Report from FDA/CFSAN",Supporting & Related Material,Report,2012-09-23T04:00:00Z,2012,9,,,2016-09-30T14:24:46Z,,0,0,090000648055c33a
FDA-1995-S-0039-0296,FDA,FDA-1995-S-0039,"References 1 through 16 re NDI 589, 3b Androsterone from Proprietary Wellness",Supporting & Related Material,Background Material,2012-07-23T04:00:00Z,2012,7,,,2016-09-30T14:24:40Z,,0,0,0900006480a3efbc
FDA-1995-S-0039-0298,FDA,FDA-1995-S-0039,Mitsibushi Gas Chemical Company (Pyrroloquinoline Quinone Disodium Salt) Report 417 - Amended Report re FDA-1995-S-0039-0141,Other,Amendment,2012-07-23T04:00:00Z,2012,7,,,2016-09-30T14:24:43Z,,0,0,09000064807649bd
FDA-1995-S-0039-0297,FDA,FDA-1995-S-0039,Mitsibushi Gas Chemical Company (Pyrroloquinoline Quinone Disodium Salt) Report 417 - Report,Other,Report,2012-07-23T04:00:00Z,2012,7,2012-07-23T04:00:00Z,,2016-09-30T14:24:42Z,,0,0,0900006480560f26
FDA-1995-S-0039-0293,FDA,FDA-1995-S-0039,"NDI 636, Extrafolate [6(R,S)-5-Methyltetrahydrofolic Acid, Calcium Salt from Gnosis S.P.A.",Other,75 Day PreMarket Notification,2012-07-19T04:00:00Z,2012,7,,,2016-09-30T14:24:35Z,,0,0,0900006480b0bc32
FDA-1995-S-0039-0295,FDA,FDA-1995-S-0039,"NDI 638,  Marine Aminos of Pink Murex [Phyllonotus Erythrostomus] from Gold Leaf Sustainable",Other,75 Day PreMarket Notification,2012-07-19T04:00:00Z,2012,7,2012-07-19T04:00:00Z,,2016-09-30T14:24:39Z,,0,0,0900006480b0e705
FDA-1995-S-0039-0294,FDA,FDA-1995-S-0039,"NDI 637, Extrafolate-S [6(S)-5-Methyltetrahydrofolic Acid, Calcium Salt] from Gnosis S.p.A.",Other,75 Day PreMarket Notification,2012-07-19T04:00:00Z,2012,7,,,2016-09-30T14:24:37Z,,0,0,0900006480b0cae1
FDA-1995-S-0039-0292,FDA,FDA-1995-S-0039,"NDI 635, Geranti Bio-Ge Yeast from Gerenti Pharm Ltd",Other,75 Day PreMarket Notification,2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,,2016-09-30T14:24:34Z,,0,0,0900006480b0bab3
FDA-1995-S-0039-0290,FDA,FDA-1995-S-0039,"NDI 632, Puresta Oil from YamahaMotor Co., LTD",Other,Report,2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,,2016-09-30T14:24:33Z,,0,0,0900006480b0a55d
FDA-1995-S-0039-0291,FDA,FDA-1995-S-0039,"NDI 634, Horse Bone Extract from Branch Corporation Finance-Investment-Construction",Other,75 Day PreMarket Notification,2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,,2016-09-30T14:24:33Z,,0,0,0900006480b0b8dd
FDA-1995-S-0039-0288,FDA,FDA-1995-S-0039,"Report 394 Amendment NDI 444 PHX Partners, LLC (Formerly PHX Health Solutions, Inc.)",Other,Report,2012-03-22T04:00:00Z,2012,3,2012-03-22T04:00:00Z,,2016-09-30T14:24:32Z,,0,0,09000064805609b6
FDA-1995-S-0039-0287,FDA,FDA-1995-S-0039,"Report 393 Amendment NDI 443 PHX Partners, LLC (Formerly PHX Health Solutions, Inc.)",Other,Report,2012-03-22T04:00:00Z,2012,3,2012-03-22T04:00:00Z,,2016-09-30T14:24:31Z,,0,0,09000064805609b3
FDA-1995-S-0039-0289,FDA,FDA-1995-S-0039,"Report 395 Amendment NDI 445 PHX Partners, LLC (Formerly PHX Health Solutions, Inc.)",Other,Report,2012-03-22T04:00:00Z,2012,3,2012-03-22T04:00:00Z,,2016-09-30T14:24:32Z,,0,0,09000064805609b8
FDA-1995-S-0039-0286,FDA,FDA-1995-S-0039,"NDI 631, Nattolife/Nattokinase Enzyme from Zytech Biotech PVT LTD",Other,75 Day PreMarket Notification,2012-03-19T04:00:00Z,2012,3,2012-03-19T04:00:00Z,,2016-09-30T14:24:30Z,,0,0,0900006480c36025
FDA-1995-S-0039-0278,FDA,FDA-1995-S-0039,"NDI 618, Sea Buckthorn Berry Juice from Meaningful Food Company",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:20Z,,0,0,0900006480fcefc4
FDA-1995-S-0039-0280,FDA,FDA-1995-S-0039,"NDI 623, Riboceine D-Ribose-L-Cysteine from Max International, LLC.",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:25Z,,0,0,0900006480c08317
FDA-1995-S-0039-0281,FDA,FDA-1995-S-0039,"NDI 624, Hydrolyzed Lignin from AVVA Pharmaceuticals AG",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2018-11-30T20:28:08Z,,0,0,0900006480c1afd8
FDA-1995-S-0039-0284,FDA,FDA-1995-S-0039,"NDI 629, Fulvic Acid from Miyamonte U.S.A., Inc",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:29Z,,0,0,0900006480c1b0d5
FDA-1995-S-0039-0283,FDA,FDA-1995-S-0039,"NDI 626, Lipowheat Oil from Hitex SAS",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:28Z,,0,0,0900006480c1b0b6
FDA-1995-S-0039-0282,FDA,FDA-1995-S-0039,"NDI 625, Obestilin from Sabinsa Corporation",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:28Z,,0,0,0900006480c1b04e
FDA-1995-S-0039-0285,FDA,FDA-1995-S-0039,"NDI 630, Mulberry Leaf Powder from Ray Farm Corporation",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:29Z,,0,0,0900006480c1b0d6
FDA-1995-S-0039-0279,FDA,FDA-1995-S-0039,"NDI 621, Fernblock from Industrial Farmaceutica Cantabria, S.A.",Other,75 Day PreMarket Notification,2012-03-05T05:00:00Z,2012,3,2012-03-05T05:00:00Z,,2016-09-30T14:24:24Z,,0,0,0900006480c08a3a
FDA-1995-S-0039-0275,FDA,FDA-1995-S-0039,Report 614 - Capterin from SanRx Pharmaceuticals  re NDI 611,Other,75 Day PreMarket Notification,2012-03-02T05:00:00Z,2012,3,2012-03-02T05:00:00Z,,2016-09-30T14:24:10Z,,0,0,0900006480ab7e4d
FDA-1995-S-0039-0276,FDA,FDA-1995-S-0039,"NDI 615, Calcium Formate from Nephro Tech LLC",Other,75 Day PreMarket Notification,2012-03-02T05:00:00Z,2012,3,2012-03-02T05:00:00Z,,2016-09-30T14:24:15Z,,0,0,0900006480ab88b7
FDA-1995-S-0039-0277,FDA,FDA-1995-S-0039,"NDI 616, Antrodia Cinnamomea from  MoTech Corporation",Other,75 Day PreMarket Notification,2012-03-02T05:00:00Z,2012,3,2012-03-02T05:00:00Z,,2016-09-30T14:24:19Z,,0,0,0900006480af05ab
FDA-1995-S-0039-0272,FDA,FDA-1995-S-0039,"NDI 610 - AsrraGrin from Nuliv Science USA, Inc.",Other,75 Day PreMarket Notification,2012-01-23T05:00:00Z,2012,1,2012-01-23T05:00:00Z,,2016-09-30T14:24:02Z,,0,0,0900006480aad124
FDA-1995-S-0039-0271,FDA,FDA-1995-S-0039,"NDI 609 -  Sonova 400 from Arcadia Biosciences, Inc.",Other,75 Day PreMarket Notification,2012-01-23T05:00:00Z,2012,1,2012-01-23T05:00:00Z,,2016-09-30T14:24:00Z,,0,0,0900006480aa9eaa
FDA-1995-S-0039-0274,FDA,FDA-1995-S-0039,"NDI 613, SelenoForce from Sabinsa Corporation",Other,75 Day PreMarket Notification,2012-01-23T05:00:00Z,2012,1,2012-01-23T05:00:00Z,,2016-09-30T14:24:04Z,,0,0,0900006480ab317a
FDA-1995-S-0039-0273,FDA,FDA-1995-S-0039,"NDI 612, Cissus Quadrangularis from Gateway Health Alliances, Inc.",Other,75 Day PreMarket Notification,2012-01-23T05:00:00Z,2012,1,2012-01-23T05:00:00Z,,2016-09-30T14:24:02Z,,0,0,0900006480aad125
FDA-1995-S-0039-0265,FDA,FDA-1995-S-0039,"Attachment X -Joh et al, Clinical Result of the Intestinal Remedy (Biothree(r) Containing Three Live Bacteria Species for Bacterial Diarhea, Progress in Medicine Vol.13 (1983) re NDI 603, Bio-Three H Powder from Josifa International, Inc.",Supporting & Related Material,Background Material,2012-01-18T05:00:00Z,2012,1,,,2016-08-15T18:54:23Z,,0,0,0900006480f990d0
FDA-1995-S-0039-0267,FDA,FDA-1995-S-0039,"NDI 606, Triclisia subcordata Oliv., Anuolu from Cornelius Babsanya-Craig",Other,75 Day PreMarket Notification,2012-01-18T05:00:00Z,2012,1,2012-01-18T05:00:00Z,,2016-09-30T14:23:58Z,,0,0,0900006480aa9a26
FDA-1995-S-0039-0269,FDA,FDA-1995-S-0039,"Literature and References, Exhibits V-Z re NDI 607- NDI 584 Amendment - Antistax Red Vine Leaf Extract from Boehringer Ingelhheim Pharmaceuticals, Inc.",Supporting & Related Material,Background Material,2012-01-18T05:00:00Z,2012,1,,,2016-08-15T20:05:35Z,,0,0,0900006480aa9bff
FDA-1995-S-0039-0264,FDA,FDA-1995-S-0039,"NDI 591, D-Ribose-L-Cysteine, Riboceine from Max International, LLC,",Other,75 Day PreMarket Notification,2012-01-18T05:00:00Z,2012,1,2012-01-18T05:00:00Z,,2016-09-30T14:23:57Z,,0,0,0900006480a3f3c5
FDA-1995-S-0039-0266,FDA,FDA-1995-S-0039,"NDI 605, Sesame Peptide KM-20 from Uniglobe Kisco, Inc.",Other,75 Day PreMarket Notification,2012-01-18T05:00:00Z,2012,1,2012-01-18T05:00:00Z,,2016-09-30T14:23:58Z,,0,0,0900006480aa87e1
FDA-1995-S-0039-0270,FDA,FDA-1995-S-0039,"NDI 608 - Lactobacillus Paracasei GM080 from GenMont Biotech, Inc.",Other,75 Day PreMarket Notification,2012-01-18T05:00:00Z,2012,1,2012-01-18T05:00:00Z,,2016-09-30T14:23:59Z,,0,0,0900006480b08de1
FDA-1995-S-0039-0268,FDA,FDA-1995-S-0039,"NDI 607 NDI 584 Amendment - Boehringer Ingelhheim Pharmaceuticals, Inc. (Antistax Red Vine Leaf Extract)",Other,75 Day PreMarket Notification,2012-01-18T05:00:00Z,2012,1,2012-01-18T05:00:00Z,,2016-09-30T14:23:59Z,,0,0,0900006480aa9bcd
FDA-1995-S-0039-0245,FDA,FDA-1995-S-0039,"References Cover Page - re NDI 587 - Androsta-1,4,6-triene-3,17-dione  from Proprietary Wellness",Supporting & Related Material,Background Material,2012-01-17T05:00:00Z,2012,1,,,2016-09-30T14:23:43Z,,0,0,0900006480a2bd3e
FDA-1995-S-0039-0255,FDA,FDA-1995-S-0039,"NDI 597, Milkweed Seed Oil (MSO) from Natural Fibers Corporation",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:52Z,,0,0,0900006480a59a3a
FDA-1995-S-0039-0246,FDA,FDA-1995-S-0039,"NDI 592 -  Androst-4-ene03,16,17-trione from Proprietary Wellness",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:47Z,,0,0,0900006480a408a1
FDA-1995-S-0039-0260,FDA,FDA-1995-S-0039,"NDI 603, Bio-Three H Powder from Josifa International, Inc.",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:55Z,,0,0,0900006480a91b4a
FDA-1995-S-0039-0247,FDA,FDA-1995-S-0039,"Cited References - re NDI 592 -  Androst-4-ene03,16,17-trione from Proprietary Wellness) (Part 1 of 3)",Supporting & Related Material,Background Material,2012-01-17T05:00:00Z,2012,1,,,2016-08-12T16:11:27Z,,0,0,0900006480a41168
FDA-1995-S-0039-0261,FDA,FDA-1995-S-0039,"Attachment V - Nomura, et al, Probiotics Reduce Infectious Complications After Pancreaticoduodenectomy, Hepato-Gastroenterology Vol.54 (2007) re NDI 603, Bio-Three H Powder from Josifa International, Inc.",Supporting & Related Material,Background Material,2012-01-17T05:00:00Z,2012,1,,,2016-08-15T18:49:26Z,,0,0,0900006480aa55d1
FDA-1995-S-0039-0254,FDA,FDA-1995-S-0039,"NDI 596,  NDI 596,  Homotaurine from Ovos Natural Health Inc from Ovos Natural Health Inc",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:51Z,,0,0,0900006480a7d6c8
FDA-1995-S-0039-0262,FDA,FDA-1995-S-0039,"NDI 604,  Adrenosterone from Propietary Wellness",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:56Z,,0,0,0900006480aa6855
FDA-1995-S-0039-0253,FDA,FDA-1995-S-0039,"Reference 1 - Hall et al, Recent Progress in the Consideration of Flavoring Ingredients Under the Food Additives Amendment, III.  GRAS Substances re NDI 595 -  Linalool Oil from Hanader Corporation",Supporting & Related Material,Background Material,2012-01-17T05:00:00Z,2012,1,,,2016-08-12T21:06:05Z,,0,0,0900006480a526bd
FDA-1995-S-0039-0256,FDA,FDA-1995-S-0039,"NDI 598, Aka-shoma Extract Powder from BHN Co., Ltd",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:52Z,,0,0,0900006480a59a3b
FDA-1995-S-0039-0259,FDA,FDA-1995-S-0039,"NDI 602,  Femblock from Industrial Farmaceutica Cantabria, S.A",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:54Z,,0,0,0900006480a913ba
FDA-1995-S-0039-0258,FDA,FDA-1995-S-0039,"NDI 600, Corbicula Fluminea from Motech Corporation",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:54Z,,0,0,0900006480a8e405
FDA-1995-S-0039-0250,FDA,FDA-1995-S-0039,"Amendment re NDI 594 - AlgaeCal from AlgaeCal, Inc.",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:49Z,,0,0,0900006480a51ea1
FDA-1995-S-0039-0263,FDA,FDA-1995-S-0039,"Attachment 1 - Mayer et al., Seasonal Changes in and Effect of Castration/Androgen Replacement on the Plasma Levels of Five Androgens in the Male Three-Spined Stickleback, Gasterosteus Aculeatus L, General And Comparative Endocrinology Vol.17 (1990) re NDI 604 - Adrenosterone from Propietary Wellness",Supporting & Related Material,Background Material,2012-01-17T05:00:00Z,2012,1,,,2016-08-12T20:10:57Z,,0,0,0900006480aa6965
FDA-1995-S-0039-0252,FDA,FDA-1995-S-0039,NDI 595 -  Linalool Oil from Hanader Corporation,Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:51Z,,0,0,0900006480a526bc
FDA-1995-S-0039-0251,FDA,FDA-1995-S-0039,"Attachment 3 - Adey, et al., Phymatolithon Calcareum (Pallas) - re Amendment NDI 594 - AlgaeCal from AlgaeCal, Inc.",Supporting & Related Material,Background Material,2012-01-17T05:00:00Z,2012,1,,,2016-08-12T21:02:52Z,,0,0,0900006480a52075
FDA-1995-S-0039-0257,FDA,FDA-1995-S-0039,"NDI 599, Niu Zhang Zhi Mycelia
Powder, Essence of Antrodia Cinnamomea Capsules from Motech Corporation",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:53Z,,0,0,0900006480a59c58
FDA-1995-S-0039-0249,FDA,FDA-1995-S-0039,"NDI 594 - AlgaeCal from AlgaeCal, Inc.",Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:48Z,,0,0,0900006480a51ea0
FDA-1995-S-0039-0248,FDA,FDA-1995-S-0039,NDI 593 - Solubilized Eggshell Membrane from  Biova LLC,Other,75 Day PreMarket Notification,2012-01-17T05:00:00Z,2012,1,2012-01-17T05:00:00Z,,2016-09-30T14:23:48Z,,0,0,0900006480a51e9f
FDA-1995-S-0039-0242,FDA,FDA-1995-S-0039,Exhibit B - Reference -1 re NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.,Supporting & Related Material,Background Material,2012-01-12T05:00:00Z,2012,1,,,2016-09-21T20:54:34Z,,0,0,0900006480a7cac8
FDA-1995-S-0039-0243,FDA,FDA-1995-S-0039,Exhibit C Cited References 1 - 7  re NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.,Supporting & Related Material,Background Material,2012-01-12T05:00:00Z,2012,1,,,2016-08-11T19:54:38Z,,0,0,0900006480a7cb53
FDA-1995-S-0039-0244,FDA,FDA-1995-S-0039,"Exhibit C - Reference 8 - Evaluation of the Health Aspects of Hesperidin, Naringin, and Citrus Bioflavonoid Extracts as Food Ingredients re Exhibit C Cited References 1 - 7  re NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.",Supporting & Related Material,Background Material,2012-01-12T05:00:00Z,2012,1,,,2016-09-30T14:23:43Z,,0,0,0900006480a7d613